The major factors that drive the growth of the amniotic membrane market is the rise geriatric population coupled with the increase in amniotic membrane based transplantation globally. However, dearth of skilled professionals and high cost of the surgeries involving amniotic membrane restrain the growth of the global amniotic membrane market. Moreover, the increase in awareness regarding the potential benefits of amniotic membrane among the patients as well as the healthcare professionals offers lucrative opportunities that boost the market.
The global amniotic membrane market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into cryopreserved amniotic membrane and lyophilization amniotic membrane. Based on application, it is divided into surgical wounds, ophthalmology, and others. Based on end user, itis classified into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the type of amniotic membrane used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane
By End User
Ambulatory Surgical Centers
Research Centers & Laboratory
KEY PLAYERS PROFILED
Skye Biologics Inc.
Amniox Medical, Inc.
Amnio Technology, LLC
Applied Biologics LLC
Alliqua BioMedical, Inc
Human Regenerative Technologies, LLC
Derma Sciences Inc
MiMedx Group, Inc
1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market Definition And Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top Winning Strategies, By Year, 2014-2017*
3.2.4. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.5. Top Winning Strategies, By Company, 2014-2017*
3.3. Porters Five Forces Analysis
3.4. Top Player Positioning
3.5. Market Dynamics
188.8.131.52. Growth in geriatric population
184.108.40.206. Increasing technological advancements and rising amniotic membrane transplantations
220.127.116.11. Increased awareness to reduce healthcare costs
18.104.22.168. Dearth of skilled professionals
22.214.171.124. Increasing awareness about the advantages of amniotic membrane transplant
CHAPTER 4: AMNIOTIC MEMBRANE MARKET BY PRODUCT
4.2. Market Size and Forecast
4.3. Cryopreserved Amniotic Membrane
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region
4.4. Lyophilization Amniotic Membrane
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region
CHAPTER 5: AMNIOTIC MEMBRANE MARKET BY APPLICATION
5.1.1. Market size and forecast
5.2. Surgical Wounds
5.2.1. Market size and forecast by region
5.3.1. Market size and forecast by region
5.4.1. Market size and forecast by region
CHAPTER 6: AMNIOTIC MEMBRANE MARKET BY END-USER
6.1.1. Market size and forecast
6.2.1. Market size and forecast by region
6.3. Ambulatory Surgical Centers
6.3.1. Market size and forecast by region
6.4. Specialized Clinics
6.4.1. Market size and forecast by region
6.5. Research Centers & Laboratory
6.5.1. Market size and forecast by region
CHAPTER 7: AMNIOTIC MEMBRANE MARKET, BY REGION
7.1.1. Market size and forecast
7.2. North America
7.2.1. North America Market size and forecast by country
7.2.2. North America Market size and forecast by Product
7.2.3. North America Market size and forecast by Application
7.2.4. North America Market size and forecast by End User
126.96.36.199. U.S. Market size and forecast by product
188.8.131.52. U.S. Market size and forecast by application
184.108.40.206. U.S. Market size and forecast by end user
220.127.116.11. Canada Market size and forecast by product
18.104.22.168. Canada Market size and forecast by application
22.214.171.124. Canada Market size and forecast by end user
126.96.36.199. Mexico Market size and forecast by product
188.8.131.52. Mexico Market size and forecast by application
184.108.40.206. Mexico Market size and forecast by end user
7.3.1. Europe Market size and forecast by product
7.3.1. Europe Market size and forecast by application
7.3.1. Europe Market size and forecast by end user
7.4.1. Asia-Pacific market size and forecast, by product
7.4.2. Asia-Pacific market size and forecast, by application
7.4.3. Asia-Pacific market size and forecast, by end user
7.5.1. LAMEA Market size and forecast by product
7.5.1. LAMEA Market size and forecast by application
7.5.1. LAMEA Market size and forecast by end user
CHAPTER 8: COMPANY PROFILES
8.1. Alliqua BioMedical Inc.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments
8.2. Amnio Technology, LLC
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments
8.3. Applied Biologics LLC
8.3.1. Company overview
8.3.2. Company snapshot
8.4. FzioMed Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.5. Human Regenerative Technologies, LLC
8.5.1. Company overview
8.5.2. Company snapshot
8.6. Integra Lifesciences Holdings Corporation (Derma Sciences Inc.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments
8.7. Katena Products, Inc. (IOP Ophthalmics)
8.7.1. Company overview
8.7.2. Company snapshot
8.8. MiMedx Group Inc.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.9. Skye Biologics Inc.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments
8.10. Tissue-Tech Inc. (Amniox Medical Inc.)
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Key strategic moves and developments
Amniotic membrane is the innermost layer forming the fetal membranes. Amniotic membrane has the ability to promote healing and hence it is being utilized in surgical procedures related to genitourinary tract, skin, brain, and head and neck. In addition, amniotic membrane can also be used as a dressing to ease ocular surface reconstruction and promote healing for various ailments.
The rise in geriatric population and the increased adoption of amniotic membrane for varied applications are the major factors that drive the growth of this market. However, dearth of healthcare professionals is the key restraint for the market growth. Moreover, the increase in awareness about the advantages of amniotic membrane in various surgical procedures that enhances the surgeries, would offer lucrative opportunities for the market growth in the foresee future.
The lyophilized amniotic membrane segment is expected to grow at a significant CAGR during the forecast period as lyophilized amniotic membrane can be stored at ambient temperatures for prolonged periods. Moreover, nearly 240 pieces of amniotic membrane are obtained from a single amnion sheet.
The surgical wounds segment accounted for the maximum share in terms of revenue in 2016 and is expected to grow at a CAGR of 8.9% during the forecast period. This is due to the challenges posed by surgical wounds as they can result in complications such as surgical ulcers.
Ambulatory surgical centers is expected to register a significant growth rate of 9.9% during the forecast period owing to the advantages of ambulatory surgical centers such as less hospital stay and faster recovery post treatment.
Key Findings of the Amniotic Membrane Market
The other applications segment accounted for about one-ninth share of the total market in 2016, and is expected to register a CAGR of 10.8% from 2017 to 2023.
The ophthalmology segment accounted for one-fourth share of the total market in 2016 and is expected to grow at a high CAGR of 11.2% during the forecast period.
The U.S. dominated the North American amniotic membrane market and is projected to grow at a CAGR of 9.2% from 2017-2023.
Hospitals end user dominated the amniotic membrane market accounting for one-third share of the total market is expected to grow at a high CAGR of 10.0% during the forecast period.
Asia-Pacific is expected to witness highest growth rate in the global market and is expected to continue this trend throughout the forecast period. This is owing to high population density and rise in disposable income across the countries such as India and China. In addition, rapid growth in geriatric population and increase in number of ophthalmic diseases in the developing economies boost the market growth. For instance, China has 2.5 million individuals suffering from cataract and an estimated one million children suffer from blindness, which is mainly caused due to vitamin A deficiency. This creates an ample demand for upgraded surgeries employing amniotic membrane, fueling the market growth.
The key players operating in the global amniotic membrane market are FzioMed, Inc., Skye Biologics Inc., IOP Ophthalmics, Amniox Medical, Inc., Amnio Technology, LLC, Applied Biologics LLC, Alliqua BioMedical, Inc., Human Regenerative Technologies, LLC, Derma Sciences Inc., and MiMedx Group, Inc. Other players operating in the value chain are AlloCure, Bellicum Pharmaceuticals, Biogen Idec, BIOTIME, Bone Therapeutics, Cell Medica, CESCA THERAPEUTICS, and Fibrocell Science.